SCHEMBL23116551

SCHEMBL23116551

CC(=O)NC(CC(C)C)CN(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
HDAC4 P56524 1/20 0.40
KISS1R Q969F8 1/20 0.34
CRAT P43155 1/20 0.34
ANPEP P15144 3/20 0.33
RNPEP Q9H4A4 2/20 0.33
DNPEP Q9ULA0 2/20 0.33
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32
PLA2G10 O15496 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
ALOX15 P16050 1/20 0.31
NFKB1 P19838 1/20 0.31
PTGS2 P35354 1/20 0.31
THPO P40225 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23116550 1.00 ALDH1A1 (0.47) ALDH1A1HDAC4KISS1RCRATANPEP
SCHEMBL28499674 0.77 ALDH1A1 (0.52) ALDH1A1KISS1RCRATRNPEPMEN1
SCHEMBL11073456 0.77 ALDH1A1 (0.52) ALDH1A1KISS1RCRATRNPEPMEN1
SCHEMBL11073459 0.77 ALDH1A1 (0.52) ALDH1A1HDAC4KISS1RCRATMEN1
SCHEMBL14294441 0.77 ALDH1A1 (0.52) ALDH1A1HDAC4KISS1RCRATMEN1
SCHEMBL15576809 0.76 CRAT (0.38) ALDH1A1CRATKMT2AKDM4EMAPT
SCHEMBL10522704 0.76 CRAT (0.38) ALDH1A1CRATKMT2AKDM4EMAPT
SCHEMBL18403738 0.75 ALDH1A1 (0.50) ALDH1A1KISS1RCRATANPEPRNPEP
SCHEMBL13136108 0.74 ACACB (0.39) ALDH1A1HDAC4KDM4EMAPTTHRB
SCHEMBL24459288 0.74 ACACB (0.39) ALDH1A1HDAC4KDM4EMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112312902-B Pd (II) -catalyzed enantioselective C-H arylation of free carboxylic acids 斯克里普斯研究学院 2022-02-18 CN disclosed
US-11021427-B2 Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids THE SCRIPPS RESEARCH INSTITUTE (US) 2021-06-01 US disclosed
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE 2021-03-25 US disclosed
CN-112312902-A Pd (II) -catalyzed enantioselective C-H arylation of free carboxylic acids 斯克里普斯研究学院 2021-02-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021427-B2 Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids PDCD1, PDK3, PDCD1LG2 ALDH1A1 135/4885HDAC4 1462/4885KISS1R 2194/4885
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS PDCD1, PDK3, PDCD1LG2 ALDH1A1 138/4885HDAC4 1480/4885KISS1R 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.